Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|August 7, 2010
HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disordersG S Getz, G D Wool, C A Reardon
Current Opinion in Lipidology|April 18, 2009
Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of actionGodfrey S Getz, Geoffrey D Wool, Catherine A Reardon
Current Atherosclerosis Reports|April 29, 2010
Biological properties of apolipoprotein a-I mimetic peptidesGodfrey S Getz, Geoffrey D Wool, Catherine A Reardon
Transfusion|April 25, 2017
Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolismGeoffrey D Wool, David Chapel, Angela Treml, et al.
Journal of Clinical Apheresis|November 9, 2018
Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the fieldJoseph H Cho, Megan Parilla, Angela Treml, et al.
American Journal of Clinical Pathology|July 7, 2023
Sensitivity and specificity of thromboelastography for hyperfibrinolysis: Comparison of TEG 5000 and TEG 6S CK LY30 systemsChristine Fuja, Timothy C Carll, Krzysztof Mikrut, et al.
Journal of Lipid Research|May 13, 2009
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptideGeoffrey D Wool, Tomas Vaisar, Catherine A Reardon, et al.
American Journal of Clinical Pathology|May 14, 2024
The utility of the dilute prothrombin time in the interpretation of antiphospholipid syndrome testingNoah A Mehr, Tanner E Storozuk, Krzysztof L Mikrut, et al.
Journal of Clinical Apheresis|August 28, 2025
The Role of Therapeutic Plasma Exchange in Treating Hypertriglyceridemia-Associated Acute Pancreatitis: A Real-World Effectiveness Analysis Using the TriNetX Global Collaborative NetworkNisar Amin, Tim Carll, Harleen Chela, et al.
Transfusion|May 19, 2022
Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumabChristine Fuja, Vishesh Kothary, Timothy Clifford Carll, et al.
Pageof 6